Abstract Submissions are Now Open!
- Please read all instructions carefully before preparing your abstract.
- Abstracts must be received by the deadline on 21 September 2026. Abstracts received after the deadline will not be considered.
- Abstracts must be submitted online via the abstract submission system only. Abstracts submitted by email will not be accepted.
- Abstract submitters will be notified regarding acceptance/rejection by mid-December 2026.
Submission Topics
Abstracts can be submitted in one of 56 topics:
The correct topic must be selected to ensure correct scoring. The content of the abstract must be topic related. The Committee reserves the right to change the topic under which the abstract was originally submitted.
Rules for Submission
Presentation Type: Abstracts may be submitted for Oral Communication Session, e-Poster Presentation or e-Poster Viewing. The Scientific Programme Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
- All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university-specific publications office (or another similar facility) or by a copy editor, prior to submission.
- Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be reproduced as submitted. No proofreading will be done. It will not be possible to modify abstracts after the submission deadline.
- The work described in the abstract must have appropriate approval in accordance with local ethical and animal experimentation regulations.
- Abstracts must be original and must not be or have been published or presented at any other meeting prior to the Congress.
- Submissions may not contain patient names, hospital ID numbers or other identifying information.
- The inclusion of trade names or brand names is not permitted in abstracts; please use generic drug names. The mention of agents or molecules must follow accepted scientific standards for publication.
Presentations must be balanced and free of any commercial or promotional content.
Conflict of interest: EPA aims to provide high-quality sessions focused on educational content that is free from commercial influence or bias. Thus, the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during the abstract submission.
An abstract can only be submitted once the “Declaration” on the online abstract platform has been read and accepted.
Please note that each person may submit up to 5 abstracts as a presenting author. Whilst the organisers will make every effort to avoid scheduling conflicts, these may still occur. In such cases, one of the listed co-authors will need to present on behalf of the submitting author.
Abstract Typing Instructions
For standardisation, the acceptable length of the abstract is limited to 3,000 characters and 45 lines, with authors’ details, headers and tables included. This also includes non-visible characters such as spaces as well as punctuation.
The abstract should be structured into the following sections:
- A title which clearly indicates the nature of the investigation
- Introduction
- Objectives
- Methods
- Results
- Conclusions
Up to three tables can be included in the Results section with the following criteria:
- Maximum number of columns: 10
- Maximum number of rows: 10
Tables count towards the total number of allowed characters and lines.
Up to three images/graphs can be included. They should be of high quality, and lettering/symbols/lines should be clear and distinct. Images will be reduced to one column width.
The system only accepts images that fulfil the following criteria:
- Image width: min. 50 pixels – max. 600 pixels
- Image height: min. 50 pixels – max. 800 pixels
- Image quality: min. 96 dpi – max. 300 dpi
- Image file size: min. 40 KB – max. 1000 KB
- Allowed file types: gif, jpg
All tables, figures, and reference citations must be referred to in the text of the abstract. If there is no reference in the text, the table/figure/reference (as applicable) will be removed from the abstract before publication.
If references are essential, they should be within the text, in the form: (Murphy et al. BJU Int 2005; 95 27-30).
Submission System Information
- Abstracts can be saved in “Draft” status to be re-edited and finalised until the submission deadline. Therefore, the submitter will be required to create a user account.
- Abstracts fulfilling all criteria can be saved in “Final submission” status. Only abstracts in “Final submission” status will be regarded as successfully submitted and considered for the Congress.
- Abstracts in “Final submission” status can be re-edited and modified until the submission deadline.
Abstract Review
The abstracts will be reviewed by the Scientific Programme Committee, the Local Organising Committee and an experienced panel of reviewers. Following notification of acceptance, scheduling information will be sent to the Abstract Submitter.
Abstract Acceptance and Publication
- Accepted abstracts will be published in an e-supplement of the European Psychiatry Journal and will be made available on the Congress website.
- Only abstracts for which the presenting author has confirmed the presentation and completed their registration by Monday 1 February 2027 will be scheduled in the scientific programme and included in the Congress Abstract e-Supplement.
- Presenting authors will receive a dedicated email with detailed instructions on how to confirm their presentation and register for the Congress. If the presenter wishes to register before receiving notification of acceptance or rejection, it is mandatory that the same user account be used for both the abstract submission and Congress registration. If different accounts are used, we may not be able to link the registration to the abstract submission, which may result in the abstract being excluded from the programme and the Congress Abstract e-Supplement.
- Submission of the abstract constitutes the authors’ consent to publication (e.g. in the European Psychiatry Abstract e-Supplement, on the Congress website, in Congress programmes, and in other promotional materials).
- Should the abstract be selected for oral presentation, the presenting author, on behalf of all authors, may have to sign an agreement to grant EPA the right to record the entire presentation (audio and slide) and subsequently use it for educational purposes (with or without a fee).
- Abstracts not adhering to these guidelines will be rejected. By submitting an abstract, authors acknowledge and accept these conditions. The final decision about acceptance of an abstract will be taken by the Scientific Programme Committee.
Abstract Withdrawal
The EPA reserves the right to withdraw any abstracts that do not meet the scientific standards of the association at any point before or after acceptance and subsequent publication in the European Psychiatry Abstract e-Supplement.
If you need to withdraw your abstract, a written statement reflecting the reasons for this decision must be sent to epa.abs@mci-group.com before Monday 1 February 2027.
View the EPA 2026 Book of Abstracts
Travel Grant Applications are Now Open!
The EPA awards Travel Grants to assist deserving abstract submitters with the travel costs related to attending the Congress. Submit your Travel Grant application along with your abstract! Travel Grants applications for the 35th European Congress of Psychiatry are open during the abstract submission period.